Process for inducing selective immunosuppression of antibodies

Drug – bio-affecting and body treating compositions – Lymphokine

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 89, 424 91, 424 92, 514 2, 514 12, 530350, 530362, 530363, 530807, A61K 3900, A61K 3912, A61K 3902, A61K 3936

Patent

active

047029072

ABSTRACT:
By coupling an antigen to a polyphenol derivative the formation of the corresponding antibody can be selectively suppressed by administration thereof to the desired subject.

REFERENCES:
patent: 3794630 (1974-02-01), Mullan et al.
patent: 3825525 (1974-07-01), Mullan et al.
patent: 3893993 (1975-07-01), Mullan et al.
patent: 4140679 (1979-02-01), Malley
patent: 4158705 (1979-06-01), Malley
patent: 4269764 (1981-05-01), Patterson et al.
patent: 4356170 (1982-10-01), Jennings et al.
Becker et al., Am J. Path, vol. 96, pp. 249-254, 1979.
Becker et al., J. Exp. Med., vol. 146(2), 1977, pp. 457-467, "Activation of Factor XII by Tobacco Glycoprotein".

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Process for inducing selective immunosuppression of antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for inducing selective immunosuppression of antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for inducing selective immunosuppression of antibodies will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1271354

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.